跳至主要内容
临床试验/ACTRN12622000683730
ACTRN12622000683730已完成未知

Can open-label placebos (OLP) augment an existing online treatment for insomnia in adults?

The University of Auckland0 个研究点目标入组 90 人开始时间: 2022年5月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Inclusion criteria
  • To participate, individuals must:
  • 1.Reported Insomnia Severity Index (ISI) score of >7.
  • 2.Have ability to read/speak English.
  • 3.Be 18 years and older.
  • 4.Have Internet access, computer access and an active email address.

排除标准

  • Exclusion Criteria
  • Participants will be excluded from the study if they:
  • 1.Have irregular sleep schedules that prevent the ability to follow intervention recommendations including night shift work, bedtimes outside of 8pm-2am or awakenings outside of 4am-10am.
  • 2.Have uncontrolled or certain medical conditions deemed to interfere with the study procedures or put the participant at undue risk. 3.Are pregnant.
  • 4.Have current psychological treatment for insomnia.
  • 5.Are currently taking medications that interfere with sleep e.g. Steroids, Dexedrine, Ritalin, Adderall, and Provigil.

研究者

相似试验